The most frightening cardiac symptom
Heart Sisters
OCTOBER 6, 2024
“The most prominent symptom I had – which kept getting stronger and would NOT go away – is the one I now warn all my friends about…”
Sun.Oct 06, 2024
100 
This is what happened when a hospital implemented the Queen of Hearts
Dr. Smith's ECG Blog
OCTOBER 6, 2024
This patient had the onset of chest pain 24 hours before arrival to the ED. An ECG was recorded immediately at triage and, at this hospital, the Queen of Hearts is routinely used to determine cath lab activation. Here is that ECG: Original ECG What do you think? There is ST depression maximal in V1-V4, which is diagnostic of posterior OMI. There is some ST Elevation and slightly hyperacute T-wave in V6.
The $197 Bonus That Comes FREE With The Heart Health Formula
Dr. Paddy Barrett
OCTOBER 6, 2024
Everyone who completes The Heart Health Formula is transformed in some way. They know more about heart disease prevention than they ever thought possible. But it does take a while to get through all the material. Several people have asked if there is a way to cover the core content of The Heart Health Formula in a shorter time frame so that they can get started.
Finerenone’s Early Heart Failure Impact
CardiacWire
OCTOBER 6, 2024
The FINEARTS-HF trial already showed that Bayer’s nsMRA finerenone (Kerendia) has the potential to slash mortality and event rates in HFpEF and HFmrEF patients, and new analysis suggests that its impact could be even greater if used earlier. Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), blocking the mineralocorticoid receptor and its blood pressure effects.
'Color Doppler stripes’ make it difficult to diagnose the severity of valvular heart diseases: a report of two cases
Cardiovascular Ultrasound
OCTOBER 6, 2024
Echocardiography remains the reference-standard imaging technique for assessing valvular heart disease (VHD), but artifacts like the ‘color Doppler stripe’ can complicate diagnosis. This artifact is not widely.
Treatment of iliac arteriovenous malformation associated with trisomy 21: a case report
Journal of Cardiothoracic Surgery
OCTOBER 6, 2024
Both arteriovenous malformation (AVM) and trisomy 21 are rare diseases. Studies have shown that individuals with trisomy 21 may have potential vascular malformations, with the main site of onset being the port.
Demographic and Regional Trends of Cardiovascular Disease and Obesity-Related Mortality in the United States From 1999 to 2021
The American Journal of Cardiology
OCTOBER 6, 2024
Publication date: Available online 5 October 2024 Source: The American Journal of Cardiology Author(s): Ishaque Hameed, Khushboo Nusrat, Adeena Jamil, Kaneez Fatima, Abdul Mannan Khan Minhas, Stephen J.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Rheumatology Month in Review: September 2024
HCPLive
OCTOBER 6, 2024
The rheumatology month in review emphasizes new trends in medication use and novel technologies' potential for managing fibromyalgia.
Novel ablation strategy to target slow conduction velocity areas in atrial fibrillation
HeartRhythm
OCTOBER 6, 2024
Recent studies demonstrate slowing conduction velocity (CV) within the cardiac tissue as a surrogate of fibrosis, suggesting that slow CV areas are associated with the perpetuation of atrial fibrillation (AF).1,2 We reported a novel approach to visualize local areas with slow CV, termed slow conduction velocity areas (SCVA) mapping, using the wave speed software of the Ensite X EP system (Abbott).3 We demonstrated that SCVAs were associated with recurrence after pulmonary vein isolation (PVI), b
Endocrinology Month in Review: September 2024
HCPLive
OCTOBER 6, 2024
Our September 2024 monthly recap in endocrinology spotlights regulatory updates, new guidelines, and the latest episodes of Diabetes Dialogue.
A multiparametric heart failure score at baseline is associated with long-term outcome in patients with remotely monitored implantable cardioverter-defibrillators: A pooled analysis of nine clinical trials
HeartRhythm
OCTOBER 6, 2024
To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a Heart Failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs).
Atopic Dermatitis Closely Linked to Prurigo Nodularis in Meta-Analysis
HCPLive
OCTOBER 6, 2024
New data reports a notably heightened risk of atopic dermatitis in patients with prurigo nodulais compared with a control cohort.
Prognostic Impact of Target Vessel in Chronic Total Occlusions: A Population-Based Cohort Study
The American Journal of Cardiology
OCTOBER 6, 2024
Publication date: Available online 5 October 2024 Source: The American Journal of Cardiology Author(s): Emil Nielsen Holck, Lars Jakosen, Lone Juul-Hune Mogensen, Ashkan Eftekhari, Evald Høj Christiansen
Analysis of different surgical approaches to the treatment of thymoma
Journal of Cardiothoracic Surgery
OCTOBER 6, 2024
Surgical approach in the treatment of thymoma is varied. This retrospective study aimed to evaluate the outcomes of different surgical approaches in the treatment of thymoma.
Sinoatrial node function and the role of sinoatrial conduction in the typical atrial flutter substrate
HeartRhythm
OCTOBER 6, 2024
Sinoatrial node (SAN) activation and sinoatrial conduction pathways (SACPs) have been assessed in animals, but not humans.
Can Exercise Injure the Sinus Node?
Circulation
OCTOBER 6, 2024
Circulation, Volume 150, Issue 15 , Page 1171-1173, October 8, 2024.
Challenges and Opportunities in Aortic Dissection: The Journey to Personalized Medicine
Circulation
OCTOBER 6, 2024
Circulation, Volume 150, Issue 15 , Page 1155-1157, October 8, 2024.
From the Literature
Circulation
OCTOBER 6, 2024
Circulation, Volume 150, Issue 15 , Page 1211-1212, October 8, 2024.
Response by McIntyre et al to Letter Regarding Article, “Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials”
Circulation
OCTOBER 6, 2024
Circulation, Volume 150, Issue 15 , Page e274-e275, October 8, 2024.
Letter by Aldaas et al Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials"
Circulation
OCTOBER 6, 2024
Circulation, Volume 150, Issue 15 , Page e273-e273, October 8, 2024.
Let's personalize your content